Impact of Race and Area Deprivation on Triple-Negative Metastatic Breast Cancer Outcomes

被引:0
|
作者
Rosenzweig, Margaret Quinn [1 ]
Nugent, Bethany [2 ]
McGuire, Meaghan [2 ]
机构
[1] Univ Pittsburgh, Sch Nursing, Nursing, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
关键词
metastatic breast cancer; survival; race; neighborhood; health disparity; NEIGHBORHOOD DEPRIVATION; SURVIVAL; DISPARITIES; INDEX; RACISM; HEALTH;
D O I
10.1188/23.ONF.449-457
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVES: To describe area deprivation, anxiety, depression, relative dose intensity of first-line metastatic breast cancer (MBC) treatment, and survival in Black and White women who had died from triple-negative MBC, including interaction analysis. SAMPLE & SETTING: This cohort study drew from a database of women who had died from MBC (N = 53). METHODS & VARIABLES: Descriptive statistics, independent t tests, analysis of variance, and Mann-Whitney U tests were used, and effect sizes were calculated. RESULTS: Compared with White women, Black women reported higher anxiety and depression at MBC baseline. Black women living in areas of higher deprivation experienced shorter overall survival than White women living in similar areas (9.9 months versus 24.6 months). These results were not statistically significant, likely because of a small sample size, but were clinically meaningful. IMPLICATIONS FOR NURSING: Black and low-income women with breast cancer experience inferior survival as compared with White and higher-income women. Newer explanatory models for racial disparity in cancer outcomes include the assessment of neighborhood deprivation. White women may be less affected by their neighborhood, even when living in areas of greater deprivation influencing cancer outcomes. This merits further exploration.
引用
收藏
页码:449 / 457
页数:9
相关论文
共 50 条
  • [21] Racial differences in outcomes of triple-negative breast cancer
    Jose M. Pacheco
    Feng Gao
    Caroline Bumb
    Matthew J. Ellis
    Cynthia X. Ma
    Breast Cancer Research and Treatment, 2013, 138 : 281 - 289
  • [22] Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities
    Parise, Carol A.
    Caggiano, Vincent
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (01) : 151 - 158
  • [23] Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study
    Swede, Helen
    Gregorio, David I.
    Tannenbaum, Susan H.
    Brockmeyer, Jessica A.
    Ambrosone, Christine
    Wilson, Lori L.
    Pensa, Mellisa A.
    Gonsalves, Lou
    Stevens, Richard G.
    Runowicz, Carolyn D.
    CLINICAL BREAST CANCER, 2011, 11 (05) : 332 - 341
  • [24] Does obesity have an effect on outcomes in triple-negative breast cancer?
    Mowad, Ronny
    Chu, Quyen D.
    Li, Benjamin D. L.
    Burton, Gary V.
    Ampil, Frederico L.
    Kim, Roger H.
    JOURNAL OF SURGICAL RESEARCH, 2013, 184 (01) : 253 - 259
  • [25] A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
    Zeichner, Simon B.
    Terawaki, Hiromi
    Gogineni, Keerthi
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2016, 10
  • [26] The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer: A Review
    Anders, Carey K.
    Zagar, Timothy M.
    Carey, Lisa A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (04) : 737 - +
  • [27] Assessing direct costs of treating metastatic triple-negative breast cancer in the USA
    Skinner, Karen E.
    Haiderali, Amin
    Huang, Min
    Schwartzberg, Lee S.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (02) : 109 - 118
  • [28] Circulating tumor cells in non-metastatic triple-negative breast cancer
    Karhade, Mandar
    Hall, Carolyn
    Mishra, Priyankana
    Anderson, Amber
    Kuerer, Henry
    Bedrosian, Isabelle
    Krishnamurthy, Savitri
    Lucci, Anthony
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 325 - 333
  • [29] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12
  • [30] Outcomes research examining treatments, quality of life and costs in HER2-negative and triple-negative metastatic breast cancer: a systematic literature review
    Parisi, Monika
    Pelletier, Corey
    Cherepanov, Dasha
    Broder, Michael S.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (01) : 67 - 83